Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX NYSE:DVA NYSE:LH NASDAQ:RCM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$201.62-0.7%$195.06$164.65▼$213.50$22.48B0.59761,106 shs1.01 million shsDVADaVita$209.29+0.3%$177.40$101.00▼$211.80$13.40B0.91771,908 shs846,299 shsLHLabcorp$264.61-0.6%$262.46$241.81▼$293.72$21.83B0.9541,400 shs461,448 shsRCMR1 RCM$14.31$14.28$12.56▼$14.32$6.04B0.844.32 million shsN/A10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics0.00%+0.94%+8.64%+1.79%+12.54%DVADaVita0.00%+8.33%+4.45%+40.67%+53.25%LHLabcorp0.00%-0.13%+6.05%-0.42%+1.77%RCMR1 RCM0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$201.62-0.7%$195.06$164.65▼$213.50$22.48B0.59761,106 shs1.01 million shsDVADaVita$209.29+0.3%$177.40$101.00▼$211.80$13.40B0.91771,908 shs846,299 shsLHLabcorp$264.61-0.6%$262.46$241.81▼$293.72$21.83B0.9541,400 shs461,448 shsRCMR1 RCM$14.31$14.28$12.56▼$14.32$6.04B0.844.32 million shsN/A10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics0.00%+0.94%+8.64%+1.79%+12.54%DVADaVita0.00%+8.33%+4.45%+40.67%+53.25%LHLabcorp0.00%-0.13%+6.05%-0.42%+1.77%RCMR1 RCM0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.50Moderate Buy$216.587.42% UpsideDVADaVita 2.38Hold$199.17-4.84% DownsideLHLabcorp 2.73Moderate Buy$308.0016.40% UpsideRCMR1 RCM 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RCM, DGX, LH, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2026DGXQuest Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B) ➝ Buy (B+)6/8/2026DVADaVita Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)5/19/2026DGXQuest Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)5/11/2026DVADaVita TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$144.00 ➝ $201.005/11/2026DVADaVita TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$144.00 ➝ $201.005/8/2026LHLabcorp Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B-)5/8/2026DVADaVita Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$158.00 ➝ $205.005/7/2026DVADaVita BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$158.00 ➝ $194.005/7/2026DVADaVita Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/7/2026DVADaVita UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$190.00 ➝ $235.005/6/2026DVADaVita Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$126.00 ➝ $220.00(Data available from 6/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$11.04B2.02$15.07 per share13.38$64.78 per share3.11DVADaVita$13.64B0.98$21.78 per share9.61($5.29) per share-39.56LHLabcorp$13.95B1.56$24.68 per share10.72$103.98 per share2.54RCMR1 RCM$2.25B2.68$0.69 per share20.89$6.66 per share2.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$992M$9.0522.2817.432.429.07%15.60%7.06%7/28/2026 (Estimated)DVADaVita$746.80M$10.7819.4111.390.685.65%-270.37%4.87%8/5/2026 (Estimated)LHLabcorp$876.50M$11.2923.4413.691.866.66%16.29%7.62%7/23/2026 (Estimated)RCMR1 RCM$3.30M-$0.15N/A71.55N/A-2.48%-2.18%-1.10%N/ALatest RCM, DGX, LH, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026DVADaVita$2.33$2.87+$0.54$2.87$3.36 billion$3.42 billion4/30/2026Q1 2026LHLabcorp$4.09$4.25+$0.16$3.35$3.51 billion$3.54 billion4/21/2026Q1 2026DGXQuest Diagnostics$2.37$2.50+$0.13$2.24$2.83 billion$2.90 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.441.71%+7.34%38.01%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.09%N/A25.51%N/ARCMR1 RCMN/AN/AN/AN/AN/ALatest RCM, DGX, LH, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/19/2026DGXQuest Diagnosticsquarterly$0.861.81%7/8/20267/8/20267/22/20264/9/2026LHLabcorpquarterly$0.721.11%5/29/20265/29/20266/11/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.671.181.08DVADaVitaN/A1.421.37LHLabcorp0.681.731.54RCMR1 RCM0.761.791.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%RCMR1 RCM61.10%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics0.88%DVADaVita1.50%LHLabcorp0.84%RCMR1 RCM36.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics57,000110.70 million109.72 millionOptionableDVADaVita78,00064.20 million63.24 millionOptionableLHLabcorp71,00082.00 million81.31 millionOptionableRCMR1 RCM30,000422.39 million266.95 millionOptionableRCM, DGX, LH, and DVA HeadlinesRecent News About These CompaniesR1 RCM names former Humana executive CIOJune 9, 2026 | beckershospitalreview.comBR1 Appoints Eric Tagliere as Chief Information OfficerJune 9, 2026 | finance.yahoo.comRCM company Coronis Health names new CEOMay 28, 2026 | beckershospitalreview.comBR1 RCM declared Top 50 Best Companies to Work for in India making it the Best in Healthcare Industry by Great Place to Work InstituteMay 22, 2026 | aninews.inAR1 RCM expands operations with new office floor, plans strong workforce growthMay 15, 2026 | telanganatoday.comTR1 RCM Expands Hyderabad OperationsMay 12, 2026 | deccanchronicle.comDR1 RCM launches new facility in cityMay 12, 2026 | thehansindia.comTUPDATE - R1 Announces Phare OS Expansion to Help Providers Navigate Growing Complexity and Margin PressureApril 15, 2026 | finance.yahoo.comR1 Announces Revenue Performance Solutions Powered by Phare OS to Help Providers Navigate Growing Complexity and Margin PressureApril 14, 2026 | finance.yahoo.comR1 RCM launches AI tools for AR recovery, denialsApril 14, 2026 | beckershospitalreview.comBOptum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe HeidiMarch 20, 2026 | fiercehealthcare.comFR1 and Heidi Announce Strategic Partnership to Improve Revenue Capture for Physician Groups and Healthcare OrganizationsMarch 10, 2026 | finance.yahoo.comR1 RCM sells 340B referral capture businessFebruary 19, 2026 | beckershospitalreview.comBR1 Appoints Andy Brailo as Chief Commercial OfficerFebruary 6, 2026 | finance.yahoo.comR1 RCM taps new chief commercial officerFebruary 5, 2026 | beckershospitalreview.comBR1 Awarded ‘Best in KLAS’ Across Multiple RCM Categories for 2026February 4, 2026 | finance.yahoo.comNuvemRx Acquires par8o from R1 RCM, Strengthening its Specialty Care Coordination and 340B Referral Capture CapabilitiesFebruary 2, 2026 | finance.yahoo.comR1 RCM launches prior authorization toolJanuary 21, 2026 | beckershospitalreview.comBR1 Prior Authorization, Now Powered by the Phare OS, Accelerates Care, Reduces Costs and Improves AccuracyJanuary 15, 2026 | finance.yahoo.comR1 Launches Phare Audit, the AI-Native Solution to Capture Full Reimbursement, Reduce Revenue Leakage and Improve QualityJanuary 9, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRCM, DGX, LH, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$201.62 -1.44 (-0.71%) Closing price 03:59 PM EasternExtended Trading$201.93 +0.31 (+0.15%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$209.29 +0.63 (+0.30%) Closing price 03:59 PM EasternExtended Trading$209.43 +0.14 (+0.07%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$264.61 -1.55 (-0.58%) Closing price 03:59 PM EasternExtended Trading$266.79 +2.18 (+0.82%) As of 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.R1 RCM NASDAQ:RCMR1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas What's Behind the Social Media Controversy Surrounding IonQ? Mission Control: Floating In SpaceX's Record-Breaking Orbit 3 Dividend Increases Investors Can Actually Trust RH’s Strong Q1 Still Leaves Investors With One Big Question SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? Alphabet's Most Overlooked Division Just Had a Big Week Robinhood Wants a Bigger Role in IPOs—Here's Why It Matters Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
